| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs13375749 |
glutaroyl carnitine |
T/C |
7256 |
0.78 |
0.030 (0.003) |
2.8·10-28 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs13375749 |
| Chromosomal location | Chr1: 53,468,470 (1p32.3) |
| Gene (distance) | CPT2 (16,014) |
| Predicted causal gene | CPT2 |
| Gene/protein classification | - |
| Metabolite (Pathway) | glutaroyl carnitine (Lysine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | CPT2 encodes carnitine palmitoyltransferase II which catalyzes the transfer of palmitate and related metabolites from carnitine to coenzyme A in the mitochondrial inner membrane [9654057]. |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | Carnitine palmitoyltransferase II (CPT II) deficiency |
| Pharmacological information |
| ChEMBL ID | CHEMBL3238 |
| Drug information |
Compounds with inhibitory activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |